Brian Feth and Jonathan Grinstein go behind the headlines to discuss the impact of a Republican administration on Federal ...

Find out more about key trends shaping solid dosage drug development and manufacturing and the changing demands impacting the market. Furthermore, gain a greater understanding about how coating design ...

Pharmaceutical Technology® caught up with Brittany Hayes, PhD, Highly Potent & Oncology Platform Director at CordenPharma, ...

Scientific inquiry is unpredictable, and the data collected today might need to answer unforeseen questions tomorrow. Rigid ...

High-throughput screening (HTS) enables the rapid testing of numerous compounds against biological targets. By automating and ...

A £520 million investment for manufacturing capacity was announced by Chancellor of the Exchequer, Rachel Reeves, but ...

Lilly has added a $1 billion investment to increase biologics manufacturing at its Limerick, Ireland, site while unveiling its new $800 million facility in Kinsale. During a presentation at the ...

Balversa (erdafitinib) marks the first and only bladder cancer therapy to target FGFR3 alterations, with a demonstrated ...

It is important to understand the differences between risk-based decision making and other decision making in a pharmaceutical quality system.

Specialty matrix drug delivery systems, like osmotic pump tablets, play an important role in patient-centric drug design. In this upcoming webinar, experts will delve into how one unique excipient, ...

In a recent survey by MJH Life Sciences™, more than 3,000 industry professionals shared their perspectives on the current state of travel for business purposes. Although vaccinations are more widely ...

In the collaboration, the new company, Oblenio Bio, has been granted an exclusive option to license LBL-051, a tri-specific T-cell engager antibody, from Leads Biolabs. With DKK 600 million (US$87.4 ...